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Skeletal muscle is characterized by a remark-
able capacity to regenerate after injury, mainly 
due to the function of satellite cells, the main 
skeletal muscle stem cells (Brack and Rando, 
2012; Wang and Rudnicki, 2012). Polycomb 
group (PcG) proteins are essential regulators of 
stem cell function during normal development 
and in adult organs. They form multi-protein 
chromatin-associated complexes that play an 
essential role in the genome-wide epigenetic-
mediated remodeling of gene expression dur-
ing myogenic differentiation of satellite cells, 
mainly through posttranslational modifications 
of histones (Asp et al., 2011). Ezh2 and Bmi1 
are required for adult satellite cell homeostasis 
and proliferation in response to muscle injury, 
an effect mediated at least in part by repression 
of the ink4a locus (Juan et al., 2011; Robson 
et al., 2011). Importantly, although Bmi1 is ex-
pressed in several types of cancer and its mecha-
nism of action may be similar in a non-neoplastic 
and neoplastic context, its overexpression does 
not initiate tumorigenesis (He et al., 2009; 
Yadirgi et al., 2011).
An emerging role for PcG proteins is their 
involvement in DNA repair (Liu et al., 2009; 
Facchino et al., 2010; Ismail et al., 2010; Ginjala 
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The Polycomb group (PcG) protein Bmi1 is an essential epigenetic regulator of stem cell 
function during normal development and in adult organ systems. We show that mild up-
regulation of Bmi1 expression in the adult stem cells of the skeletal muscle leads to a 
remarkable improvement of muscle function in a mouse model of Duchenne muscular 
dystrophy. The molecular mechanism underlying enhanced physiological function of Bmi1 
depends on the injury context and it is mediated by metallothionein 1 (MT1)–driven modu-
lation of resistance to oxidative stress in the satellite cell population. These results lay the 
basis for developing Bmi1 pharmacological activators, which either alone or in combination 
with MT1 agonists could be a powerful novel therapeutic approach to improve regeneration 
in muscle wasting conditions.
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Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
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et al., 2011; Pan et al., 2011). Bmi1/-derived cells show 
significant mitochondrial dysfunction accompanied by sus-
tained increase in reactive oxygen species (ROS) production 
that are sufficient to engage the DNA repair pathway (Liu 
et al., 2009), which is in turn impaired, thus leading to a mag-
nified cellular damage. The balance between intracellular ROS 
and antioxidant molecules is vital in determining the rate of 
oxidative damage accumulation and the impaired function of 
satellite cells in aging and in myopathies, in which decreased 
anti-oxidative capacity has been documented (Fulle et al., 
2005; Whitehead et al., 2006; Tidball and Wehling-Henricks, 
2007). X-linked Duchenne muscular dystrophy (DMD) is the 
most common primary myopathy caused by the loss of the 
dystrophin protein from the plasma membrane, which causes 
loss of its integrity and fiber damage during repeated cycles of 
muscle degeneration and regeneration (Duncan, 1989). The 
proliferative capacity of myogenic cells was reported to be 
rapidly exhausted in dystrophin-deficient muscle, also because 
they are more sensitive to oxidative stress injury, leading to 
reduced and defective regeneration of the muscle as the dis-
ease progresses (Blau et al., 1983, 1985; Disatnik et al., 1998). 
Moreover, enzymatic adaptations to exercise-induced pro-
duction of ROS and free radical damage are significantly de-
creased in dystrophic compared with normal muscles (Faist 
et al., 1998, 2001). Overall, an impaired protection against ROS 
in dystrophic muscle appears to contribute to disease progres-
sion as also indicated by the beneficial, albeit transient, effect 
of antioxidants in ameliorating the skeletal muscle pathophysi-
ology of DMD patients (Whitehead et al., 2008).
Metallothionein 1 (MT1) and MT2 are ubiquitously ex-
pressed (Kägi and Hunziker, 1989) low molecular weight, 
cysteine–rich zinc binding proteins. Although the role of 
MT1 in promoting cell proliferation is controversial (Smith 
et al., 2008), studies on MT-null liver cells showed their failure 
to regenerate after oxidative stress injury (Oliver et al., 2006).
Here, we show that overexpression of Bmi1 in the satellite 
cells significantly improves muscle strength through enhanced 
MT1-mediated protection of these cells from oxidative stress 
in a mouse model of dystrophinopathies but not after acute 
traumatic injury.
RESULTS
Bmi1 expression in mouse models of acute traumatic  
and chronic degenerative skeletal muscle injuries
To understand the potential impact of fine tuning Bmi1 expres-
sion in muscle injury, we characterized its expression profile 
in satellite cells at representative time points (3 and 10 d after Figure 1. Bmi1 expression in mouse models of acute and chronic 
skeletal muscle injuries. (a) Schematic representation of satellite cell 
isolation after freeze injury in C57BL/6J mice. (b) Relative Bmi1 expression 
represented as 1/dCT values at 3 d.a.i. and 10 d.a.i. (mean ± SEM from 
three independent experiments with n = 3 uninjured, n = 3 3 d.a.i., and  
n = 2 10 d.a.i.; ***, P < 0.001). (c) Immunofluorescence for Pax7 and Bmi1 
on muscle sections from uninjured mice, injured mice (10 d.a.i.), and mdx 
mice (representative results from n = 4 uninjured, n = 2 3 d.a.i., n = 2 10 
d.a.i., and n = 4 mdx). Arrows indicate Bmi1 staining intensity (expression 
level) in Pax7+ve satellite cells in three different conditions (uninjured,  
10 d.a.i., and mdx). (d) Quantification of Bmi1 staining of Pax7+ve cells with 
pixel intensity above 400 at 3 and 10 d.a.i. compared with uninjured con-
trols (mean ± SEM from two independent experiments with n = 4 unin-
jured, n = 2 3 d.a.i., n = 2 10 d.a.i., and n = 4 mdx; *, P < 0.05). (e) Bmi1 
expression in satellite cells obtained from mdx single fibers after switch-
ing from growth to differentiation-inducing culturing conditions (48 h in 
differentiation conditions) compared with control satellite cells (mean ± 
SEM from two independent experiments with n = 3 for each condition;  
*, P < 0.05). Bar, 50 µm.
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(Fig. 1, c and d [quantification]). Interestingly, although Bmi1 
expression increased significantly in control satellite cell cultures 
obtained from single fibers after switching from growth to 
differentiation-inducing conditions, no significant change was 
observed in mdx satellite cells (Fig. 1 e). These results show that 
the levels of Bmi1 expression are differentially regulated during 
the regenerative process in a pathological specific context.
Conditional Bmi1 expression increases the satellite cell pool 
and does not prevent myogenic differentiation in vitro
To explore the biological effect of enhancing Bmi1 expression 
in the satellite cells, we used a mouse line where Bmi1 ex-
pression can be activated in a cell- and time-specific fashion 
upon Cre-mediated recombination (Yadirgi et al., 2011). 
Transduction of satellite cell cultures derived from STOP-
FloxBmi1 muscles with Adeno-Cre (A-Cre) virus induced effi-
cient recombination and increased Bmi1 expression at protein 
injury [d.a.i.]) in a well-established model of acute traumatic 
muscle injury: the freeze injury model (Gayraud-Morel et al., 
2007). Satellite cells were isolated 3 and 10 d.a.i. by magnetic 
activated cell sorting using SM/C-2.6 antibody (Fukada et al., 
2004; Fig. 1 a). qRT-PCR analysis revealed significant in-
crease in the expression of Bmi1 in these cells at both time 
points (Fig.1 b), a result which was confirmed by an increased 
percentage of Pax7+ve cells expressing high level of Bmi1 in 
the muscle tissue, as assessed by double immunolabeling 
for Bmi1 and Pax7 and quantification of staining intensity 
(van der Laak et al., 2000; Gavet and Pines, 2010; Fig. 1, 
c and d [quantification]).
The mdx mouse is a well characterized model of chronic 
degenerative muscle pathology (Bulfield et al., 1984), which is 
genetically and biochemically similar to the human DMD 
(Collins and Morgan, 2003). We observed down-regulation 
of Bmi1 expression in Pax7+ve satellite cells in the muscle tissue 
Figure 2. Conditional Bmi1 activation in satellite cell cultures increases the percentage of Pax7+ve cells. (a and b) Satellite cells derived from P60 
STOPFloxBmi1 single fibers, infected with A-GFP or A-Cre viruses and immunostained for Bmi1 (representative results from three independent experiments 
with n = 3 for each condition). (c and d) Levels of expression of Bmi1 are analyzed with WB (c; representative blot from 2 independent experiments with n = 4 
biological samples) and qRT-PCR on the same samples (d; mean ± SEM from three independent experiments with n = 3 for each condition; ***, P < 0.001). 
(e and f) Representative images (e; 6 independent experiments with n = 8 for each condition) of satellite cell cultures infected with either A-GFP or A-Cre 
viruses (Bmi1Over cells; f) and stained for Pax7, MyoD, and MyHC, 2 and 5 d.a.i. in differentiation conditions. (g and h) Quantification of the findings in nor-
mal (g; mean ± SEM from six independent experiments with n = 8 for each condition; *, P < 0.05) and dystrophic context (h; mean ± SEM from 4 indepen-
dent experiments with n = 4 for each condition; **, P < 0.01). (i and j) Representative images of the BrdU staining on A-GFP (i) and A-Cre–infected satellite 
cells (j) in four different conditions (six independent experiments with n = 8 for each condition): growth, 2 d differentiation, 5 d differentiation, and re-
stimulation (i and j). (k) Quantification of BrdU+ve cells in growth, differentiation, and upon high serum restimulation conditions compared with A-GFP–
infected satellite cells (mean ± SEM from six independent experiments with n = 8 for each condition; *, P < 0.05; ***, P < 0.001). (l) Quantification of Pax7+ve 
satellite cells in Bmi1Over satellite cells compared with A-GFP–infected satellite cells in growth, differentiation, and upon high serum restimulation conditions 
(mean ± SEM from four independent experiments with n = 4 for each condition; *, P < 0.05; **, P < 0.01). Bars, 62.5 µm. Bmi1Over: Bmi1-overexpressing cells.
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satellite cells were isolated from mdx;STOPFloxBmi1 mus-
cles (Fig. 2 h).
To investigate whether these results could be explained 
by modulation of satellite cell proliferation by Bmi1, satellite 
cells were treated with BrdU in four different culturing con-
ditions: growth (proliferation medium), early differentiation 
(2 d in differentiation medium), late differentiation (5 d in 
differentiation medium), and restimulation (2 d in prolifera-
tion medium after 5 d of differentiation, Fig. 2, i and j). 
Under growth conditions, 59% of Bmi1Over satellite cells had 
incorporated BrdU compared with 44% of the controls, and 
in early and late differentiation, 40% as compared with 5% 
and 8% as compared with 2%, respectively (Fig. 2, i, j, and k 
[quantification]). These results indicate that Bmi1 overex-
pression prolongs proliferation even in differentiation-inducing 
conditions. When satellite cell cultures were returned to high 
serum conditions after 5 d of differentiation (restimulation), 
(Fig. 2, a–c) and RNA level (Fig. 2 d) compared with Adeno-
GFP (A-GFP)–infected cells.
Next, satellite cell cultures derived from single fibers 
isolated from the SOL muscle of postnatal day 60 (P60) 
STOPFloxBmi1 mice were infected with A-GFP or A-Cre 
virus and induced to differentiate by switching to low serum 
conditions for 2 d (Fig. 2, e–g). The number of Pax7+ve  
cells was increased by 14% in cultures overexpressing Bmi1 
(Bmi1Over), whereas no alteration in the proportion of MyoD+ve 
cells (29% in both conditions) was found (Fig. 2, e, f, and g 
[quantification]). The higher number of Pax7+ve;MyoD-ve 
cells in Bmi1Over cultures suggested that the stem cell pool of 
satellite cells was increased (Fig. 2 g). Importantly, Bmi1 over-
expression in satellite cells derived from P60 mice did not 
inhibit differentiation and the percentage of MyHC+ve cells 
remained constant as compared with controls (Fig. 2, e, f, 
and g [quantification]). Similar results were obtained also when 
Figure 3. Conditional activation of Bmi1  
expression in satellite cells improves muscle 
strength in dystrophic muscles in vivo.  
(a) Schematic temporal summary of the experiment.  
(b and c) Quantification of Bmi1 expression upon 
Tamoxifen injections in mdx;Pax7Bmi1 mice compared 
with controls at RNA (b, mean ± SEM from four inde-
pendent experiments with n = 12 mdx;Pax7Bmi1 and  
n = 12 mdx; ***, P < 0.001) and at protein level (c; arrow-
heads indicate a Pax7+ve cell then included in the in-
sert, representative results from two independent 
experiments with n = 4 mdx, n = 3 mdx;Pax7Bmi1, n = 12 
fields for mdx, and n = 11 fields for mdx;Pax7Bmi1).  
(d) Quantification of Bmi1 pixel intensity in 
mdx;Pax7Bmi1 mice compared with controls (mean ± 
SEM from two independent experiments with n = 4 
mdx, n = 3 mdx;Pax7Bmi1, n = 12 fields for mdx, and  
n = 11 fields for mdx;Pax7Bmi1; ***, P < 0.001). (e) The 
progression of the muscle pathology is followed by 
the forelimb grip strength test before each treadmill 
session. The table reports the statistical significant 
differences between groups and the coefficient rep-
resenting the improving (if positive) or worsening  
(if negative) of the phenotype (four independent 
experiments with n = 5 controls, n = 9 mdx, n = 11 
mdx;Pax7Bmi1; mdx vs. mdx;Pax7Bmi1: **, P < 0.01;  
mdx vs. control: ***, P < 0.001; and control vs. 
mdx;Pax7Bmi1: *, P < 0.05). (f and g) Quantification of 
Pax7+ve cells in mdx;Pax7Bmi1 and mdx control (f) and 
quantification of double-positive cells Pax7+ve/Ki67+ve 
in mdx;Pax7Bmi1 and mdx control (g; mean ± SEM 
from n = 3 mdx, n = 7 mdx;Pax7Bmi1; *, P < 0.05).  
(h) Representative images of muscle sections stained 
for Pax7 and Ki67 in mdx;Pax7Bmi1 as compared with 
mdx mice (n = 3 mdx, n = 7 mdx;Pax7Bmi1; *, P < 
0.05). Mdx;Pax7CreERT2;STOPFloxBmi1: mdx;Pax7Bmi1 
(Bmi1 overexpression in satellite cells in a dystrophic 
environment). Bars: (c) 125 µm; (h) 62.5 µm.
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staining, revealed activation of the construct in 75% of 
the Pax7CreERT2;R26R injected mice (unpublished data). 
LacZ/Laminin double labeling confirmed the specificity of 
the recombination in satellite cells (unpublished data). FACS 
analysis revealed that at least 65% of the satellite cells isolated 
from Pax7CreERT2;R26R muscles by means of M-Cadherin 
labeling (Cooper et al., 1999) were -galactosidase positive, 
hence confirming high recombination efficiency (unpub-
lished data).
To test the hypothesis that Bmi1 overexpression in satellite 
cells could enhance regeneration in a chronic injury model, 
triple transgenic mice mdx;Pax7CreERT2;STOPFloxBmi1, 
here called mdx;Pax7Bmi1, were generated. Mdx mice are more 
susceptible to exercise-induced injury, and a cycle of forced 
exercise on a treadmill has often been applied to accelerate 
muscle pathology and to test the efficacy of novel treatments in 
preclinical trials (De Luca et al., 2003; Whitehead et al., 2006). 
incorporation of BrdU was found in 12% of the cells, whereas 
almost 70% of the Bmi1Over satellite cells incorporated BrdU 
after 2 d of growth restimulation (Fig. 2, i, j, and k [quantifi-
cation]). Importantly, at this time point a higher number of 
Pax7+ve cells was observed, in keeping with an increase in the 
pool of satellite cells even after a prolonged induction of dif-
ferentiation (Fig. 2 l).
Conditional activation of Bmi1 expression in satellite  
cells improves muscle strength in dystrophic muscles  
but not after traumatic injury in vivo
To assess the impact of Bmi1 overexpression on muscle re-
generation in vivo, we used an inducible CreER line tar-
geting satellite cells (Pax7CreERT2; Mourikis et al., 2012). 
Crosses with the R26R reporter mouse (Soriano, 1999), 
followed by Tamoxifen-mediated activation of Cre expres-
sion in double transgenic mice and whole mount LacZ 
Figure 4. Conditional activation of Bmi1 expression 
in satellite cells does not improve skeletal muscle re-
generation after traumatic injury in vivo. (a) Schematic 
temporal summary of the experiment. (b–d) Quantification 
of Bmi1 expression upon Tamoxifen injections in Pax7Bmi1 
mice compared with controls at RNA (b; mean ± SEM from 
two independent experiments with n = 5 controls and n = 3 
Pax7Bmi1; *, P < 0.05) and at protein level (via double immuno-
labeling for Pax7 and Bmi1; c; arrows indicate a Pax7+ve 
cell that is included in the insert, representative results from 
one experiment with n = 3 controls and n = 3 Pax7Bmi1); 
quantification of the average pixel intensity of Bmi1 stain-
ing in Pax7+ve cells (d; mean ± SEM with n = 3 controls and 
n = 3 Pax7Bmi1; ***, P < 0.001). (e) H&E staining of hind limbs 
10 d.a.i. in injured controls and injured Pax7Bmi1 mice (top, 
representative results from two independent experiments 
with n = 6 controls and n = 3 Pax7Bmi1). Gomori Trichrome 
staining for endomysial fibrosis in the same samples of H&E 
(injured controls and injured Pax7Bmi1 mice; bottom; repre-
sentative pictures from one experiment with n = 3 controls 
and n = 3 Pax7Bmi1). (f) Quantification of the ratio of regen-
eration in Pax7Bmi1 mice compared with controls (f, mean ± 
SEM from two independent experiments with n = 6 controls 
and n = 3 Pax7Bmi1). (g) Quantification of the CSA distribu-
tion of CNF in injured Pax7Bmi1 and injured controls: the 
percentage of CNF of control mice (gray), Pax7Bmi1 mice 
(blue), and the distribution of mature fibers (striped gray) is 
shown (mean ± SEM from two independent experiments 
and five independent experiments with n = 8 injured con-
trols, n = 3 Pax7Bmi1, and n = 15 uninjured controls; *, P < 
0.05; **, P < 0.01; ***, P < 0.001). (h) Treadmill performance 
in terms of the time run (h, mean ± SEM from three inde-
pendent experiments with n = 12 uninjured controls, n = 7 
injured controls and n = 3 Pax7Bmi1. **, P < 0.01) in injured 
control mice (gray) as compared with uninjured mice 
(striped), as well as in the distances run (i; mean ± SEM 
from three independent experiments with n = 7 injured 
controls, n = 3 Pax7Bmi1, and n = 12 uninjured controls;  
*, P < 0.05; **, P < 0.01). Bars, 125 µm.
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was up-regulated (5.73 ± 2.03-fold) also in Bmi1Over cultures 
upon restimulation (Fig. 6 a, last two bars on the right). IPA 
system biology analysis on all differentially expressed genes 
Triple transgenic mice, mdx, and nontransgenic littermates 
were injected with Tamoxifen, followed by a 6-wk period of 
running on a treadmill for 30 min twice weekly (Fig. 3 a). 
Bmi1 overexpression was confirmed both at RNA level in 
whole muscle tissue (Fig. 3 b) and at protein level specifi-
cally in the targeted satellite cells by double immunolabeling 
for Pax7/Bmi1 (Fig. 3, c and d [quantification]). Before each 
treadmill session, a forelimb grip test was performed to 
follow the progression of the disease. The forelimb strength 
of mdx mice was clearly compromised compared with con-
trols (Fig. 3 e) but the strength of both groups (mdx and con-
trol littermates) was stable throughout the duration of the 
experiment. Strikingly, mdx;Pax7Bmi1 mice showed a signifi-
cant improvement in muscle strength from the fourth week 
onwards (Fig. 3 e).
Histological examination of the muscle did not reveal 
morphological differences between mdx and mdx;Pax7Bmi1, in 
particular an impact on the degree of endomysial fibrosis or 
on adipose tissue dedifferentiation was excluded (unpublished 
data). Immunolabeling for Pax7 showed an increased per-
centage of Pax7+ve cells in mdx;Pax7Bmi1 mice as compared 
with mdx controls (Fig. 3, h and f [quantification]). Double 
labeling for Pax7 and the proliferation marker Ki67 revealed 
that it was the Ki67ve component of the Pax7+ve population 
which was increased in mdx;Pax7Bmi1 (Fig. 3, h and g [quan-
tification]), suggesting that at this time point overexpression 
of Bmi1 in Pax7+ve cells had increased the pool of quies-
cent satellite cells in a dystrophic environment. Interestingly, 
when a muscle freeze injury (FZ) was performed on the TA 
of hind limbs of Pax7CreERT2;STOPFloxBmi1 compound 
mutant mice—here called Pax7Bmi1—after Tamoxifen injection 
(Fig. 4 a) to induce Bmi1 overexpression (Fig. 4, b–d), no sig-
nificant differences were found morphologically (Fig. 4, e–g) 
or functionally (Fig. 4, h and i) in injured Pax7Bmi1 as com-
pared with injured controls.
Transcriptome analysis reveals increased expression of MT1 
in satellite cells upon activation of Bmi1 expression
To gain insights into the downstream mechanisms mediating 
the observed phenotype, we first analyzed the canonical Bmi1 
downstream target genes p16ink4a, p19Arf, and p21waf1/cip1. No 
changes were found in the expression level of these genes in 
Bmi1over satellite cells cultured under differentiation-inducing 
conditions or upon restimulation (unpublished data). Alterna-
tive ink4a/p21-independent mechanisms were then explored 
by whole-genome transcriptome analysis on the same cultures 
(Illumina platform mouse v2). A set of 254 genes was identi-
fied (Table S1), the expression of which was deregulated in 
satellite cell cultures overexpressing Bmi1 compared with 
controls (P < 0.05 and absolute fold change > 1.9). Out of 
10 genes (Ahnak, Bmi1, DNAjb6, Ehd1, Hspd1, Itgb1, Klf6, 
MT1, p21waf1/cip1, and Tpm4) selected for validation analysis, 
all but one (p21waf1/cip1) were confirmed to be differentially 
expressed (Figs. 5 a and 6 a; and not depicted). MT1 was the 
most significantly up-regulated gene (5.27 ± 0.99-fold) in 
these cultures (Fig. 6, a and b) and importantly, its expression 
Figure 5. Validation of deregulated genes and Ingenuity (IPA) sys-
tem biology analysis. (a) Genes chosen for validation in Bmi1Over satellite 
cell cultures compared with A-GFP–infected controls (mean ± SEM from 
two independent experiments with n = 3 for each condition; *, P < 0.05; 
**, P < 0.01; ***, P < 0.001). (b and c) System biology analysis using the 
Ingenuity platform reporting genes in the top canonical pathways (b) and 
the top tox lists (c; n = 3 for each condition). (d and e) qRT-PCR analysis 
of expression of redox homeostasis genes in Bmi1Over satellite cell cultures 
compared with A-GFP–infected controls (mean ± SEM from three inde-
pendent experiments with n = 5 for each condition; *, P < 0.05; **, P < 
0.01) and in Bmi1/ satellite cell cultures as compared with controls  
(e; mean ± SEM from two independent experiments with n = 4 for each 
condition; *, P < 0.05; **, P < 0.01; ***, P < 0.001).
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MT1 is a crucial mediator of the enhanced satellite  
cell pool elicited by Bmi1 overexpression in vitro
Because the DMD pathology is linked to accumulation of 
ROS in satellite cells with a consequent increase in the oxi-
dative stress induced cellular damage (Rando et al., 1998; 
Zhuang et al., 2001; Wozniak and Anderson, 2007), we ana-
lyzed whether Bmi1 overexpression would exert a protective 
role against oxidative stress-induced cellular damage in sat-
ellite cells. We observed a decrease in ROS production in 
Bmi1Over satellite cell cultures incubated with the fluorescent 
dye H2DCFDA, followed by flow cytometry (Fig. 6 c, white 
and black bars), which led to decreased oxidative damage to 
the cells as assessed by 8-hydroxydeoxyguanosine (8-OHdG) 
staining, a marker of oxidative stress-dependent DNA dam-
age (Won et al., 1999; Fig. 6, e and d [quantification]).
showed hypoxia signaling in the cardiovascular system, p53 
signaling, and protein ubiquitination pathway (Fig. 5 b) to 
be the most significantly deregulated top canonical path-
ways. Hypoxia-inducible factor signaling and NRF2-mediated 
oxidative stress response were most significantly affected 
among the top tox lists (Fig. 5 c). To further extend and 
validate these findings, the expression of a selection of genes 
involved in Bmi1-mediated control of redox homeostasis 
through generation of ROS (Liu et al., 2009) was analyzed. 
We found a significant repression of Alox15, Bnip3L, Cdo1, 
and Duox2 (Fig. 5 d). Down-regulation of MT1 expres-
sion (Fig. 6 a, first two bars; and Fig. 7 a) and increased ex-
pression of Alox5, Bnip3L, Cdo1, Duox1, and Duox2 in 
Bmi1/ satellite cells confirmed the specificity of these 
associations (Fig. 5 e).
Figure 6. The satellite cell pool is in-
creased by Bmi1 overexpression in vitro 
via up-regulation of MT1. (a) Relative ex-
pression level of MT1 in Bmi1/, Bmi1Over, 
and control satellite cells (mean ± SEM from 
two independent experiments with n = 3 for 
each condition; *, P < 0.05; **, P < 0.01).  
(b) Expression levels of MT1 are also analyzed 
at the protein level in Bmi1 Over satellite cells 
both in growth and differentiation-inducing 
conditions (left, three independent experi-
ments with n = 3 for each condition). Efficient 
knock down of MT1 is also shown in prolifera-
tion (P) and differentiation (D) conditions  
(b, right; representative results from three 
independent experiments with n = 3 for each 
condition). WB analysis of the levels of 3-NT 
modification in Bmi1Over satellite cells both in 
proliferation and differentiation-inducing 
conditions (b, left; three independent experi-
ments with n = 3 for each condition). (c) The 
amount of ROS production is measured via 
DCFDA relative fluorescence intensity in 
Bmi1Over satellite cells compared with controls 
and treated with either sh Scramble or knock-
down of MT1 (mean ± SEM from two inde-
pendent experiments with n = 4 for each 
condition; *, P < 0.05; ***, P < 0.001).  
(d and e) Quantification of the percentage of 
strongly 8OHdG+ve satellite cells in Bmi1Over 
cultures with and without knockdown of MT1 
(mean ± SEM from two independent experi-
ments with n = 4 for each condition;  
*, P < 0.05) and representative examples of 
immunolabeling (e) are shown. (f) Represen-
tative examples of immunolabeling for Pax7 
and Edu in Bmi1Over satellite cell cultures upon 
MT1 knockdown (two independent experi-
ments with n = 4 for each condition). (g) Quantification of the percentage of Edu+ve or Pax7+ve or Edu+ve/Pax7+ve cells is shown (mean ± SEM from two 
independent experiments with n = 4 for each condition; *, P < 0.05). (h) Total concentration of nitrosylated proteins (ng/µl) in Bmi1Over mdx;Bmi1Over satel-
lite cells compared with A-GFP–infected controls, with and without Mt1 knockdown (mean ± SEM from two independent experiments with n = 4; ***, P < 
0.001; *, P < 0.05). (i and j) The level of SNO-Mef2c is shown in mdx;Bmi1Over satellite cells compared with controls A-GFP–infected satellite cells as assessed 
by a modified biotin switch assay, followed by immunoblot (i) and quantification (j; mean ± SEM from two independent experiments with n = 4; *, P < 0.05). 
MT1: Metallothionein1; 8OHdG: 8-HydroxydeoxyGuanosine; MT1 up: MT1 up-regulation; MT1 nc: MT1 not changed. Bars: (e) 125 µm; (f) 62.5 µm.
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cells isolated from Bmi1/ mice showed increased ROS pro-
duction (Fig. 7 b), increased number of 8-OHdG+ve cells (Fig. 7, 
c and d [quantification]), and increased levels of 3-NT in 
Bmi1/ muscles and satellite cell cultures (Fig. 7 a), hence sup-
porting the interpretation that the observed protection from 
oxidative stress is a Bmi1-dependent effect.
Bmi1-driven improved muscle strength in dystrophic mice  
is mediated by MT1 up-regulation
Next, we assessed whether up-regulation of MT1 mediates 
the improved muscle strength observed in the mdx model 
upon Bmi1 overexpression in satellite cells. MT1 up-regulation 
was detected in 33% of mdx;Pax7Bmi1 (Fig. 8 a). Importantly, 
no MT1 up-regulation was ever detected in mdx control 
mice (Fig. 8 a), in keeping with a Bmi1-induced effect. Re-
evaluation of the muscle strength data with focus on MT1 
expression revealed that mdx;Pax7Bmi1 mice with MT1 up-
regulation were the animals with the best improvement in 
forelimb grip strength (Fig. 8 b) as compared with mdx con-
trol mice. mdx;Pax7Bmi1 mice up-regulating MT1 showed 
a behavior similar to that of unaffected control mice, whereas 
mdx;Pax7Bmi1 with no MT1 up-regulation showed a perfor-
mance comparable to mdx control mice (Fig. 8 b). These 
findings show that Bmi1-induced MT1 up-regulation mo-
lecularly mediates the impact of Bmi1 overexpression on mus-
cle strength. Furthermore, centrally nucleated fiber (CNF) 
percentage was significantly reduced in mdx;Pax7Bmi1 with 
MT1 up-regulation compared with mdx control mice and to 
mdx;Pax7Bmi1 mice without MT1 up-regulation (Fig. 8, c and d 
[quantification]), suggesting that muscle fibers were more re-
sistant to exercise-induced damage in mdx;Pax7Bmi1 with MT1 
up-regulation. The reduced number of H2AX+ve (a marker 
of DNA double-strand break) satellite cells detected in these 
mice (double immunofluorescence for Pax7 and H2AX; 
Fig. 8, e and f [quantification]) is in keeping with the protec-
tive effect having been exerted specifically on the satellite cells. 
We did not observe differences in the number of apoptotic 
These findings suggest that the amount of oxidative dam-
age incurred by satellite cells in vitro depends on Bmi1 expres-
sion levels and raise the possibility that this effect is mediated 
by MT1. To test this hypothesis functionally, we set out to 
knock down MT1 expression (MT1kd) in both Bmi1Over and 
mdx;Bmi1Over cultures and we analyzed ROS production, 
the percentage of 8-OHdG+ve cells, and the number of pro-
liferating satellite cells and/or Pax7+ve cells. Western blot analy-
sis confirmed efficient knockdown of MT1 in mdx;Bmi1Over 
cultures in growth and in differentiation conditions (Fig. 6 b). 
A significant increase in ROS production was observed upon 
MT1kd in Bmi1Over and in mdx;Bmi1Over satellite cells (Fig. 6 c 
and not depicted) with concomitant increase in the percent-
age of 8-OHdG+ve cells (Fig. 6, d and e) and significantly fewer 
EdU+ve, Pax7+ve and EdU+ve;Pax7+ve cells (Fig. 6, f and g 
[quantification]), compared with controls treated with scram-
bled sequences.
Under stress conditions, cytotoxicity is also caused by ex-
cessive production of peroxynitrite anions, which react with 
tyrosine in proteins generating 3-nytrotyrosine (3-NT) resi-
dues, an irreversible oxidative modification (Vasilaki et al., 
2007). 3-NT is regarded as a sensitive measure of oxidative 
damage to myofibrillar proteins and results in impaired con-
tractile function of the muscle in addition to contributing to 
the impairment of the satellite cell function (Vasilaki et al., 
2007; Sakellariou et al., 2011). We found that the levels of 
3-NT were significantly decreased in satellite cells upon Cre-
mediated Bmi1 overexpression (Fig. 6, b [WB analysis] and h 
[ELISA]), an effect which was dependent on MT1 up-regulation, 
as shown by the reversal of the effect upon MT1kd in mdx; 
Bmi1Over satellite cells (Fig. 6 h). Importantly, reduced nitro-
sylation upon Bmi1 overexpression was confirmed also on a 
specific protein, Mef2c (Fig. 6, i and j [quantification]), known 
to play an essential role in the muscle regenerative process (Liu 
et al., 2014; Panda et al., 2014) and to be inhibited by nitrosyl-
ation in the context of oxidative stress-induced protein dam-
age (Ryan et al., 2013). Experiments performed on satellite 
Figure 7. Increased ROS production and oxidative-
stress induced DNA and protein damage in Bmi1/ 
cells is accompanied by MT1 down-regulation. (a) Pro-
tein analysis of MT1 and 3-NT levels in Bmi1/ muscle 
tissue and satellite cells cultures (representative results 
from three independent experiments with n = 3 for each 
condition). (b) The amount of ROS production is measured 
via DCFDA relative fluorescence intensity in Bmi1/ satel-
lite cells compared with controls isolated from both SOL 
and EDL and cultured either in growth or differentiation 
conditions (mean ± SEM from two independent experi-
ments with n = 4 for each condition; *, P < 0.05; **, P < 
0.01; ***, P < 0.001). (c) Immunolabeling for 8-OHdG in 
Bmi1/ satellite cell cultures and controls (representative 
results from two independent experiments with n = 4 for 
each condition). (d) Quantification of 8-OHdG+ve cells in 
Bmi1/ satellite cell cultures and controls in both growth 
and differentiation conditions (mean ± SD from two inde-
pendent experiments with n = 4 for each condition;  
**, P < 0.01; ***, P < 0.001). Bar, 125 µm.
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Figure 8. Bmi1-driven improved muscle strength in dystrophic mice is mediated by concomitant up-regulation of MT1. (a) Relative expression 
of MT1 in mdx;Pax7Bmi1 compared with mdx control mice (mean ± SEM from three independent experiments with n = 19 mdx, n = 4 mdx;Pax7Bmi1 Mt1 
UP, n = 6 mdx;Pax7Bmi1 Mt1 nc, and n = 5 controls; *, P < 0.05). (b) mdx;Pax7Bmi1 forelimb grip strength test is reanalyzed taking into account MT1 up-
regulation (mean from four independent experiments with n = 19 mdx, n = 4 mdx;Pax7Bmi1 Mt1 UP, n = 6 mdx;Pax7Bmi1 Mt1 nc, n = 5 controls; control vs 
mdx: ***, P < 0.001; control vs. mdx;Pax7Bmi1 Mt1 UP: control vs. mdx;Pax7Bmi1 Mt1 nc: ***, P < 0.001). (c) H&E staining of representative fields of forelimbs 
of controls, mdx, and mdx;Pax7Bmi1 with and without MT1 up-regulation (representative results from four independent experiments with n = 6 controls,  
n = 19 mdx, n = 4 mdx;Pax7Bmi1 Mt1 UP, and n = 6 mdx;Pax7Bmi1 Mt1 nc). (d) Quantification of CNF of mdx;Pax7Bmi1 with and without MT1 up-regulation 
in mdx;Pax7Bmi1 MT1 up mice, mdx;Pax7Bmi1 MT1 nc, and mdx mice (mean ± SEM from four independent experiments with n = 6 controls, n = 19 mdx,  
n = 4 mdx;Pax7Bmi1 Mt1 UP, and n = 6 mdx;Pax7Bmi1 Mt1 nc; mdx vs. mdx;Pax7Bmi1 Mt1 UP: *, P < 0.05; mdx vs mdx;Pax7Bmi1 nc UP: *, P < 0.05). (e and f) Immuno-
labeling for Pax7 and H2AX (e, representative results from n = 5 mdx, n = 4 mdx;Pax7Bmi1 Mt1 UP, and n = 6 mdx;Pax7Bmi1 Mt1 nc; arrowhead: 
H2AX+ve;Pax+ve; arrow: Pax7+ve) in mdx;Pax7Bmi1 MT1 UP compared with mdx controls and mdx;Pax7Bmi1 MT1 nc (f [quantification]; mean ± SEM from  
n = 5 mdx, n = 4 mdx;Pax7Bmi1 Mt1 UP, and n = 6 mdx;Pax7Bmi1 Mt1 nc; *, P > 0.05). (g) The activities of mitochondrial respiratory chain enzymes including 
complex I (NADH: ubiquinone oxidoreductase (CI)), complex II (succinate:ubiquinone oxidoreductase (CII)), and complex IV (cytochrome c oxidase (CIV)) 
and the matrix marker citrate synthase (CS) are determined in post–600 g supernatants prepared from frozen gastrocnemius muscle samples from mdx 
and mdx;Pax7Bmi1 mice either up-regulating MT1 or not. Activities (calculated relative to mitochondrial protein) are shown relative to those observed in 
mdx mice (denoted 100% activity; mean ± SEM from one experiment with n = 5 mdx, n = 4 mdx;Pax7Bmi1 MT1 UP, and n = 6 mdx;Pax7Bmi1 MT1 nc; **, P < 
0.01). (h) Quantification of double staining for Pax7 and Cleaved Caspase3 (cCasp3) on the forelimb of mdx and mdx;Pax7Bmi1 mice with up-regulation of 
MT1 and mdx;Pax7Bmi1 mice with MT1 nc after 6 wk of treadmill exercise (mean ± SEM from one experiment with n = 5 mdx, n = 4 mdx;Pax7Bmi1 MT1 UP, 
and n = 5 mdx;Pax7Bmi1 MT1 nc). Bars, 62.5 µm.
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satellite cells or in the total number of apoptotic nuclei (dou-
ble immunolabeling for Pax7 and cCaspase3; Fig. 8 h and not 
depicted), or in the percentage of necrotic fibers (not de-
picted), but a generalized decrease in mitochondrial oxidative 
enzyme activities was detected by means of in vitro biochem-
ical analysis in mdx;Pax7Bmi1 with MT1 up-regulation (Fig. 8 g). 
To functionally validate these findings, we transplanted satel-
lite cells isolated from mdx;STOPFloxBmi1 mice induced 
to overexpress Bmi1 in vitro and either up-regulating MT1 
(Bmi1-induced) or not (ShRNA-MT1 mediated knock-
down) into the TA muscle of young mdx mice. We show 
that the contribution of the cells to the regenerative process 
was more efficient when MT1 was up-regulated, as demon-
strated by the reduced number of donor satellite cell–derived 
GFP-positive fibers upon MT1 knockdown (Fig. 9, a and b 
[quantification]).
Bmi1 expression is reduced in patients affected by DMD
To translate the significance of these findings to human pathol-
ogy, we analyzed the expression of Bmi1 in DMD muscles 
and in morphologically normal controls. Four DMD patients 
aged 2.2, 3.2, 6.1, and 9.5 yr and six age-matched controls 
were used. Reduction of Bmi1 expression was found in DMD 
muscle biopsies at all ages (Fig. 10 a). Immunolabeling for 
Bmi1 performed on adjacent sections confirmed a reduc-
tion in the number of Bmi1+ve cells in DMD cases (Fig. 10, 
a and b) and double labeling for Bmi1 and Pax7 revealed 
lower levels of Bmi1 expression in Pax7+ve satellite cells in 
Figure 9. MT1 up-regulation is essential for the efficient 
contribution of Bmi1Over satellite cells to muscle regenera-
tion upon transplantation in the mdx mouse. (a) Satellite 
cells are isolated from mdx;STOPFloxBmi1 mice, cultured for  
14 d, infected with A-Cre virus to activate Bmi1 expression,  
and treated either with Sh scramble and Mt1 knockdown, both 
viruses expressing GFP in infected cells. 6 d after treatment, the 
cells are transplanted in the TA muscles of mdx recipient mice. 
The transplanted muscles are collected after 27 d. Representa-
tive pictures of mdx muscles transplanted with A-Cre; 
mdx;STOPFloxBmi1 + Sh Scr satellite cells (a, left) or A-Cre; mdx;STOPFloxBmi1 + Sh MT1 satellite cells (a, right) are shown (a, representative results from 
n = 4 for each condition). (b) Quantification of GFP+ve fibers in A-Cre; mdx;STOPFloxBmi1 + Sh MT1 transplanted satellite as compared with A-Cre; 
mdx;STOPFloxBmi1 + Sh MT1 transplanted satellite (mean ± SEM from one experiment with n = 4 A-Cre;Mdx;STOPFloxBmi1+Sh Scr and n = 4 Mt1 A-Cre;
Mdx;STOPFloxBmi1+ShMt1; *, P < 0.05). Bar, 125 µm.
Figure 10. Bmi1 expression is reduced in 
the muscle of human DMD cases. (a) H&E 
staining of a DMD case as compared with an 
age-matched morphologically normal control. 
The same muscles are double stained for Bmi1 
and Pax7 (representative results from two 
different cases). (b) Quantification of Bmi1+ve 
cells in DMD muscle biopsies and age matched 
controls (mean ± SEM from two independent 
experiments with n = 2 control and DMD in 
both age groups, five high power fields/case;  
*, P < 0.05; **, P < 0.01). (c) Levels of expression 
of Bmi1 are analyzed by qRT-PCR in the mus-
cle biopsies of DMD patients as compared with 
age matched unaffected muscles (mean ± 
SEM from two independent experiments, n = 3 
control and n = 2 DMD in both age groups, 
two technical replicas for each case; *, P < 
0.05; **, P < 0.01). (d) Expression levels of MT1 
are measured by qRT-PCR in the muscle biop-
sies of DMD patients >5 yr compared with 
age-matched unaffected muscles (mean ± 
SEM from two independent experiments with 
n = 3 control and n = 2 DMD in both age 
groups, two technical replicas for each case;  
*, P < 0.05; **, P < 0.01). Bar: (H&E) 62.5 µm; 
(immunofluorescence) 31 µm.
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pool seen in dystrophic muscle conditions after repeated de-
generation/regeneration cycles. Genome-wide transcriptome 
analysis of satellite cells overexpressing Bmi1 revealed signifi-
cantly increased expression of MT1, which has been shown 
to be necessary to maintain proliferation and normal cellular 
functions under stress conditions, including when cells reen-
ter the cell cycle from a quiescent state (Zbinden et al., 2010). 
In keeping with this notion, improvement of muscle strength 
is seen only in those mdx mice in which up-regulation of 
MT1 occurred concomitantly with overexpression of Bmi1 
in satellite cells. The reduced contribution to regeneration 
after transplantation in a dystrophic environment of Bmi1Over 
satellite cells upon MT1 knockdown lends additional support 
to this conclusion. At present it is unclear why up-regulation 
of MT1 occurs only in a proportion of mdx mice over-
expressing Bmi1 and it will be important to investigate this fully 
in future studies. However, the correlation of muscle strength 
and MT1 up-regulation suggests that Bmi1 exerts its effect 
through protection against oxidative stress-induced cellular 
damage in vitro and in vivo, hence delaying muscle wasting 
through reduction of ROS-induced oxidative stress. The reduc-
tion of H2AX+ve satellite cells observed in the mdx;Pax7Bmi1 
with concomitant MT1 up-regulation is in keeping with this 
conclusion, as it is the MT1-dependent reduction of 3-NT 
levels in mdx;Pax7Bmi1 satellite cell cultures and the reduced 
levels of nitrosylated Mef2c, a transcription factor with an es-
sential role in muscle regeneration (Liu et al., 2014; Panda 
et al., 2014). We also observed a decrease in metabolic and mi-
tochondrial oxidative enzyme activities in these mice, raising 
the possibility that because satellite cells are better protected 
against exercise-induced oxidative stress in a dystrophic envi-
ronment, metabolic adaptation is less prominent. Although 
additional studies will be required to fully elucidate the im-
pact of Bmi1 overexpression on metabolism, it is intriguing 
that decreased mitochondrial oxidative phosphorylation ac-
tivities have been shown to increase resistance to metabolic 
diseases through prevention of ROS accumulation (Pospisilik 
et al., 2007) and to be associated with better tolerance to 
oxidative stress (Patel et al., 2013). It is currently unclear 
what mediates Bmi1-induced up-regulation of MT1 expres-
sion in the skeletal muscle. As the main mode of function 
of PcG genes is through transcriptional repression, it is possi-
ble to speculate that a MT1 repressor may be involved in 
this process.
Finally, we show here an important correspondence of 
Bmi1 expression between mice and humans, including its 
depletion in human DMD muscles. Interestingly there is evi-
dence that MT1 expression increases in human skeletal mus-
cle 24 h after intense exercise (Urso et al., 2006); here, we 
show decreased expression of MT1 in human DMD muscle, 
raising the possibility that manipulation of Bmi1 expression 
could be a useful approach to enhance satellite cell–driven 
regeneration also in human primary myopathies. Identifying 
novel pharmacological agents to enhance and sustain muscle 
regeneration in DMD is highly desirable as they could have 
a tremendous impact on DMD therapy either alone or, most 
DMD patients (Fig. 10 a). Importantly, reduced expression of 
Bmi1 (Fig. 10 c) and MT1 (Fig. 10 d) was detected also in 
DMD patients at the RNA level.
DISCUSSION
Here, we show for the first time that mild overexpression of 
a chromatin modifier gene has a functionally relevant impact 
on muscle regeneration. Bmi1 overexpression in satellite cells 
confers enhanced protection from exercise-induced injury 
and improves muscle strength in a mouse model of DMD. 
We also demonstrate that the mechanism underlying the ef-
fect of enhanced physiological function of Bmi1 in the satel-
lite cells is mediated by MT1-driven modulation of resistance 
against oxidative stress.
Skeletal muscle is an important and highly relevant plat-
form to assess how manipulation of stem cell properties may 
enhance a functionally significant regenerative process in vivo. 
We show that the expression level of Bmi1 is modulated in re-
sponse to pathological conditions in the satellite cells. Indeed, 
Bmi1 is up-regulated upon freeze injury in wild-type mice, 
whereas reduction of the proportion of Pax7+ve cells with high 
Bmi1 expression is found in the mdx mouse, with the latter 
finding corroborated by the lack of Bmi1 up-regulation in mdx 
satellite cell cultures upon induction of differentiation. In keep-
ing with these findings, overexpression of Bmi1 in satellite cells 
has a beneficial effect solely in the mdx mouse, where down-
regulation of its expression was observed.
The best characterized molecular mechanisms mediating 
Bmi1 function relies on transcriptional repression of the ink4a 
locus, encoding for p16ink4a and p19arf ( Jacobs et al., 1999), as 
well as of p21waf1/cip1. However, we found no change in the 
expression levels of these genes upon activation of Bmi1 ex-
pression raising the intriguing possibility that a novel mecha-
nism may mediate the observed phenotype. The generation 
of free radicals and ROS/reactive nitrogen species (RNS) 
is a physiological, continuous process in aerobic organisms. 
When the production of ROS/RNS exceeds the endoge-
nous antioxidant buffering capacity, oxidative stress-induced 
cellular damage occurs. There is increasing evidence that oxi-
dative stress level is elevated in diseases such as DMD and in 
normal aging (Fulle et al., 2004; Whitehead et al., 2006; 
Jackson, 2009; Cozzoli et al., 2011; Spassov et al., 2011). 
Bmi1 has an important role in mitochondrial function and 
redox homeostasis in thymocytes and in neurons (Liu et al., 
2009; Abdouh et al., 2012); however, the mechanisms medi-
ating this role of Bmi1 are currently unclear. Up-regulation 
of Bmi1 expression in Pax7+ve satellite cells increases the pool 
of quiescent Ki67ve cells in vivo after 6 wk of training on a 
treadmill, indicating that Bmi1 is involved in the regulation 
of self-renewal of these cells. To explain these results, two 
scenarios can be envisaged: it is possible that a phase of in-
creased proliferation has also occurred in vivo, perhaps im-
mediately after induction of Bmi1 overexpression in a similar 
fashion as we observed in vitro. Alternatively, satellite cells 
overexpressing Bmi1 are better able to reenter quiescence, 
hence preventing the typical exhaustion of the satellite cell 
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Studies Hybridoma Bank), mouse anti-Pax7 (1:1; Developmental Studies 
Hybridoma Bank), rabbit anti-Ki67 (1:300; Novacastra), rabbit anti-H2AX 
(phosphor S139)–DNA double-strand break marker (1:200; Abcam), and rab-
bit anti-cleaved Caspase3 (cCasp3; 1:200; Cell Signaling Technology). The 
following secondary antibodies were used: donkey anti–mouse IgG Alexa 
Fluor 488 (1:500), goat anti–mouse IgG Alexa Fluor 488 (1:1,000), goat 
anti–mouse IgG1 Alexa Fluor 546 (1:1,000), donkey anti–rabbit IgG Alexa 
Fluor 488 (1:500), donkey anti–rabbit IgG Alexa Fluor 647 (1:500), goat 
anti–rabbit IgG Alexa Fluor 546 (1:1,000), goat anti–rabbit IgG Alexa Fluor 
488 (1:1,000), donkey anti–goat Alexa Fluor 568 (1:500), rabbit anti–goat 
Alexa Fluor 488 (1:1,000), goat anti–mouse IgG2a Alexa Fluor 488 (1:1,000), 
goat anti–chicken Alexa Fluor 594 (1:1,000), goat anti–rat Alexa 488 (1:1,000; 
all from Invitrogen), and biotinylated goat anti–mouse IgG (H+L) (ready to 
use; Abcam).
Microscopy and quantification. Fluorescent and bright field image cap-
ture was performed using an epifluorescent (Leica) or confocal (Meta 510 
LSM or LSM 710; Zeiss) microscope. In myoblast cultures, all DAPI-
positive cells and antigen-positive cells were counted and the percentage of 
Antigen+ve cells was calculated. Data from three or more cultures were 
pooled to give a population mean ± SEM.
For the quantification of the intensity staining, all samples were stained 
simultaneously and the pictures were acquired with an LSM 710 confocal 
microscope at the same ratio of emissions. For the analysis with ImageJ soft-
ware (National Institutes of Health), the shape of each Pax7+ve cell was drawn 
around the nucleus and the intensity of Bmi1 staining calculated for each cell 
as mean of integrated density (mean intensity × area). The mean integrated 
density was calculated among all cells per each field acquired. The percentage 
of cells above or below certain pixel intensity (determined by the mean inte-
grated density between all measured cells) was calculated out of the total 
number of measured cells per each muscle section analyzed. The method was 
also validated using Definiens Tissue Studio (IF) 2.1.1, action library 3.6.1, 
and Developer XD 2.1.1 (Definiens AG). In particular for the validation on 
sections stained for Pax7 and Bmi1, an initial analysis was performed using 
Tissue Studio to identify the nuclei based on DAPI stain and Pax7. Nuclei 
were identified using a stain threshold of 1.62 (RGB space converted to HSD 
model to give a range of 0–2; van der Laak et al., 2000) and typical size of 
18 µm2. Pax7 was processed twice using thresholds of 0 and 25 (RGB space) 
to classify all nonnuclear tissue (Marker 1) and areas with significant Pax7 
staining (Marker 2), respectively. These are overlaid to give classifications of 
marker 1 and markers 1 and 2. Developer was used to perform post-processing 
on the classification resultant from Tissue Studio. Before classification of 
nuclei as positive or negative, nuclei with area <5 µm2 were merged with 
connecting nuclei. In cases where these small nuclei did not border another 
nucleus, no change occurred. In cases where a small nucleus borders multiple 
nuclei, the merge resulting in the lowest elliptical fit was selected. Several dy-
namic thresholds were calculated for each image: the mean Pax7 stain inten-
sity for each area classified as marker 1 was used to give Pax7 Background; 
areas of marker 1 <10 µm2 were excluded from this calculation to prevent 
skewing of resultant threshold toward the upper limit of 24 because these are 
generally isolated areas within the intensely stained regions (markers 1 and 2) 
just below the threshold of 25. The threshold for classifying nuclei as positive 
Pax7 threshold was calculated as: maximum Pax7 pixel value  (2 × Pax7 
Background). A second set of thresholds were calculated based on the Bmi1 
stain to segment positive nuclei staining as below mean, low intensity, and 
high intensity. The mean Bmi1 stain intensity in all pixels with intensity <50 
(RGB space) gives mean Bmi1, and the range between mean Bmi1 and the 
maximum Bmi1 value was divided by two to give low Bmi1 and high Bmi1. 
Nuclei with more than five pixels with Pax7 greater than Pax7 threshold 
were classified as positive nuclei. Positive nuclei were then segmented based 
on BMI1 stain as below mean, low intensity, and high intensity. To compare 
this analysis with the manual analysis with ImageJ, the mean Bmi1 intensity 
for each single slice of the stack where Bmi1 was on focus was multiplied to 
the area (in pixel) so to obtain integrated density values. The percentage of cells 
above or below certain pixel intensity (determined by the mean integrated 
importantly, in combination with genetic therapies aiming at 
reconstituting dystrophin expression.
MATERIALS AND METHODS
Animals. The following transgenic lines were used: C57BL/6J-BL/10, 
STOPFloxBmi1 (Yadirgi et al., 2011), Bmi1/ (van der Lugt et al., 1994), 
R26R (Soriano, 1999), mdx (Bulfield et al., 1984), and Tg:Pax7CreERT2 
(Mourikis et al., 2012). Animals were genotyped with PCR on gDNA ex-
tracted from ear notches according to standard protocols. Published primer 
sequences were used. All procedures had Home Office approval (Animals 
Scientific Procedures Act 1986, PPL 70/7275).
Satellite cell culture. Single fibers from the soleus (SOL) and the exten-
sor digitorum longus (EDL) muscles of adult Bmi1/, STOPFloxBmi1, 
mdx;STOPFloxBmi1, and nontransgenic littermates were isolated and cul-
tured to obtain pure satellite cell cultures according to standard protocols. In 
brief, the muscles were dissected from P60 mice being careful not to stretch 
the muscles. Tendon and other connective tissues were carefully removed 
and the muscles incubated in 0.2% Collagenase type 1 (Worthington Bio-
chemical Corporation) at 37°C for 2 h. Fibers were liberated by gentle tritu-
ration in DMEM. Single fibers were placed in a 24-well plate (BD) coated 
with 1mg/ml Geltrex Reduced Growth Factor Basement Membrane Matrix 
in DMEM (Invitrogen) and allowed to adhere for 5 min at 37°C before 
500 µl of plating medium was added (DMEM supplemented with 10% horse 
serum [PAA] and 0.5% chick embryo extract [Gibco] with antibiotics) and 
incubated at 37°C in 5% CO2. After 3 d, the media was changed to prolifera-
tion media (DMEM supplemented with 20% FCS [PAA] and 2% chick em-
bryo extract [Gibco] plus antibiotics). To induce differentiation, satellite cells 
were plated at 2,000 cells per well in an 8-well chambered slides (BD) and 
cultured in differentiation media (DMEM supplemented with 2% horse 
serum and antibiotics) for 2 or 5 d. Satellite cells derived from the same fiber 
of STOPFloxBmi1 and mdx;STOPFloxBmi1 mice were set up in parallel 
wells and treated with either A-GFP or A-Cre (Akagi et al., 1997) at the 
time of plating in the differentiating media. To control for nonspecific ef-
fects of viral treatment and overexpression of any exogenous proteins, infec-
tion with A-GFP was used as control for all experiments where A-Cre 
infection was performed.
Magnetic activated satellite cells sorting. TA muscles were isolated 
from C57BL/6J mice at time zero (uninjured controls), and 3 and 10 d after 
freeze injury. The muscles were dissected and finely chopped with scissors 
and incubated with 0.2% Collagenase in DMEM for 30 min at 37°C while 
gently shaking (250 rpm). This step of the procedure was performed twice. 
The cells were then filtered with 30-µm filters (Miltenyi Biotec). 1 ml 
of serum was added and the suspension was centrifuged for 20 min at 
1,200 rpm at 4°C. The supernatant was decanted and the staining was per-
formed with the SM/C-2.6 antibody (Fukada et al., 2004; 1:200 for 40 min 
on ice) and with anti-Biotin MicroBeads (Miltenyi Biotec) as secondary 
antibody according to manufacturer’s protocol. After magnetic sorting the 
cells were centrifuged 20 min at 2,500 rpm and the pellet was snap frozen 
on dry ice.
Immunohistochemistry. All myoblast cultures and muscle sections were 
fixed with 4% PFA for 4 and 10 min, respectively. For immunolabeling, pri-
mary antibodies were applied overnight at room temperature; appropriate 
fluorescent secondary antibodies were used and the myogenic cultures or 
sections were mounted using VECTASHIELD mounting medium with 
DAPI (Vector Laboratory). The following primary antibodies were used: 
chicken anti–-galactosidase (1:1,000; Abcam), mouse anti-Bmi1 (1:500; 
Millipore), goat anti-Bmi1 (1:100; Santa Cruz Biotechnology, Inc.), Click-iT 
TM EdU Imaging kits (Invitrogen), rabbit anti-Laminin (1:1,000; Sigma- 
Aldrich), mouse monoclonal to Metallothionein 1 (1:50; Abcam), rabbit 
anti-Myf5 (C-20; 1:100; Santa Cruz Biotechnology, Inc.), mouse anti-MyoD 
(5.8A; 1:100; Novacastra), rabbit anti-MyoD (1:100; Santa Cruz Biotechnol-
ogy, Inc.), mouse anti-pan myosin heavy chain (A4.1025; 1:10; Developmental 
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Noxa sense, 5-GAACGCGCCAGTGAACCCAA-3, and antisense, 
5-CTTTGTCTCCAATCCTCCGG-3; P16Ink4a sense, 5-CCAAGA-
GCAGAGCTAAATCC-3, and antisense, 5-CCTTCGCTCAGTTTC-
TCAT-3; P19Arf sense, 5-CCCACTCCAAGAGAGGGTTT-3, and 
antisense, 5-TCTGCACCGTAGTTGAGCAG-3; P21 sense, 5-GAC-
AAGAGGCCCAGTACTTC-3, and antisense, 5-CTCTTGCAGAAGA-
CCAATCTG-3; Tpm4 sense, 5-CCGGAGGTATCTGAACTAAAG-3, 
and antisense, 5-CAGGTCATCGATTGTCTTCTC-3.
Western blot. EDL and SOL muscles were mechanically chopped and 
lysed for 1 h on ice with RIPA buffer (1% Igepal CA-630, 2 M TrisHCl, 
pH 8.0, 0.5% Na-deoxycholate, 0.1% SDS, 2 mM EDTA, and 150 mM 
NaCl including proteinase inhibitor complete mini) followed by max speed 
centrifugation (10 min). The supernatants were collected and the protein 
concentration was measured using BCA Protein Assay kit (Thermo Fisher 
Scientific). 90 µg of protein per lane were separated on a NuPage 4–12% 
Bis-Tris Gel (Invitrogen) for 1 h at 200 V and electroblotted onto nitrocel-
lulose PROTRAN (GE Healthcare) for 2 h at 35 V. After blocking over-
night (ON) in TBST buffer (25 mM Tris HCl, 137 mM NaCl, and 0.1% 
Tween 20, pH 7.5) containing 5% skimmed milk, immunodetection of 
proteins was performed with the following antibodies: mouse anti–3-NT 
antibody (1:200, ON at 4°C; Cayman), anti-MT1 antibody (1:500, ON 
at 4°C; Abcam), mouse anti-Bmi1 (Millipore), mouse anti-Mef2C (1:1,000; 
Cell Signaling Technology), followed by HRP-conjugated anti–mouse IgG 
secondary antibody (1:5,000 for 1 h; GE Healthcare) at room temperature. En-
hanced chemoluminescence (ECL Plus; GE Healthcare) was used for detection 
of the bands. -Tubulin (1:5,000; Sigma-Aldrich) was used as a control for gel 
loading followed by anti–mouse IgG HRP (1:5,000; GE Healthcare).
When satellite cells were analyzed, cell pellets were collected from dif-
ferent culture conditions and lysed with RIPA buffer as mentioned above. 
40 µg of protein extracted from cell samples was loaded per lane on the Nu-
Page 4–12% Bis-Tris gel.
Production of shRNA-Mt1 lentiviral vector. A pGIPZ-lentiviral 
shRNAmir vector containing a hairpin sequence targeting MT1 is commer-
cially available from Open Biosystems. The shRNA-containing lentiviral 
vector was cotransfected with lentiviral packaging, using the calcium phos-
phate method into 293T cells. The medium was refreshed and viruses were 
harvested after 48 h of transfection, passed through 0.45-µm filters, concen-
trated by PEG precipitation, and stored at 80°C. The infectious titer was 
determined by FACS analysis of GFP-positive 293T cells.
Lentiviral-mediated Mt1 knockdown. Satellite cells were seeded in 
multiple-well plates and transduced with concentrated lentivirus containing 
shRNA that targets MT1, along with A-Cre (to induce Bmi1 overexpres-
sion) in proliferation medium. The medium was replaced on the second day. 
96 h after transduction, cells were switched to differentiation medium for 
48 h and the transduction efficiency was analyzed. Cells were collected for 
Western blot, immunocytochemistry, or ROS assay.
ROS assay. Satellite cells were treated with 40 µM H2DCFDA in differen-
tiation medium for 1 h at 37°C before being harvested and resuspended in 
500 µl of PBS. Cells were then immediately processed for flow cytometry 
analysis using an LSRII instrument (BD) and the relative fluorescence inten-
sity was calculated.
ELISA for 3-NT detection. Satellite cells prepared from mdx;STOPFloxBmi1 
EDL muscles were transfected with A-Cre to overexpress Bmi1 and a pro-
portion then treated with LV-shMt1. Cells infected with A-GFP were 
used as controls. Proteins were extracted from the cells and concentration 
was measured by BCA protein assay kit (Thermo Fisher Scientific). The 
amount of 3-NT protein in the lysates was determined by the Nitrotyrosine 
ELISA kit (Abcam) according to the manufacturer’s protocol. The OD was 
recorded at 450 nm and the data were analyzed with the program XLfit 
5.3.1.3 (IBDS).
density between all measured cells) was calculated out of the total number of 
measured cells per each muscle section analyzed.
For the analysis of satellite cells in vitro, satellite cells were stained for 
Bmi1 and counterstained with DAPI. Immunofluorescent images taken at 
16-bit were analyzed using ImageJ and Developer XD (2.1.1; Definiens AG). 
The analysis in ImageJ was conducted using the same settings as above. For 
the analysis in Definiens, pixels with intensity above 30 (RGB space) were 
classified as nucleus, those below 30 remained unclassified; and small unclassi-
fied areas bordering only nucleus were reclassified as nucleus and merged in. 
The distance of each pixel classified as nucleus to unclassified was then calcu-
lated to facilitate the splitting of connected nuclei. Nuclei with irregular 
shapes (roundness >0.5; roundness is based on the difference between the 
largest enclosing ellipse and the smallest enclosed ellipse) were then segmented 
based on these distances; local minima provide seeds for nuclei. These seeds 
were then grown to fill the space originally classified as nuclei, with separate 
nuclei growing to share a border rather than joining, thus splitting connected 
nuclei. Nuclei with area < 100 µm2 were then removed. For each nucleus, 
the sum of the Bmi1 staining for each pixel was exported and this value was 
multiplied for the area of each single nucleus. For both the analyses, the fold 
change of increased Bmi1 staining was calculated using the average of Bmi1 
staining of A-GFP–infected cells as one per each coverslip analyzed.
RNA extraction and qPCR analysis. Satellite cell cultures were harvested 
after 48 h of either differentiation or restimulation. The cell pellets were lysed 
in RLT buffer from RNeasy Micro purification kit (QIAGEN). Total RNA 
was isolated using the same kit. Digestion with DNase (on column) was per-
formed to remove genomic DNA. cDNA synthesis was performed with 
SuperScript III Reverse transcription kit (Invitrogen). For the sorted satellite 
cells, the retrotranscription was performed with QuantiTect Whole Tran-
scriptome kit (QIAGEN) according to manufacturer’s protocols. Analysis of 
gene expression was performed with a Rotor-Gene apparatus (Corbett Life 
Science) using SYBR Green JumpStart TaqReadyMix (Sigma-Aldrich) ac-
cording to the manufacturer’s instruction. A list of the primers used is 
reported. The Ct values of all the genes analyzed were normalized with 
GAPDH and fold changes were calculated. qRT-PCR analysis for Bmi1 was 
performed with TaqMan assays (Applied Biosystems) with FAM-labeled 
probes in 96-well plates using the 7500 RT-PCR machine (Applied Biosys-
tems) according to the manufacturer’s instructions (Bmi1: Mm 00776122_gH). 
The cDNA content was normalized against the expression of the house-
keeping gene -actin (Mm 00607939_s1). Technical duplicates for each 
culture or muscle tissue and three or more independently derived 
cultures or biological samples were analyzed. The following primers 
were used in qPCR experiments: Alox5 sense, 5-CATGTTACCGC-
TGGATCA-3, and antisense, 5-CCACTCCATCCATCTATACTG-3; 
Alox15 sense, 5-GACTTGGCTGAGCGAGGACT-3, and antisense, 
5-CTTGACACCAGCTCTGCA-3; Bmi1 sense, 5-GTTCACAAGAC-
CAGACCACTAC-3, and antisense, 5-CTGCAACCTCTCCTC-
TATCTTC-3; Bnip3L sense, 5-CTGAGCACACCTTCTGCCAGC-3, 
and antisense, 5-TAGGGATCATGCTTACAATAGGTC-3; Cdo1 sense, 
5-GTGGATCAAGGAAATGGGA-3, and antisense, 5-CTTGATCATCT-
CGTTGGA-3; Dnajb6 sense, 5-AAGTTGCTCCATGGCTACTAC-3, 
and antisense, 5-AGCTACAGCCTTCACTTGACT-3; Duox1 sense, 
5-CTGTACCTCGATGGACCGTTTGGAGA-3, and antisense, 5-AGT-
CCTTGTCACCCAGATGAAGTAGA-3; Duox2 sense, 5-TCCATCCT-
CAAAGACCTGGTCTTCA-3, and antisense, 5-CTCAGCCAGCT-
GAGTAATGTAGATGT-3; Ehd1 sense, 5-GGTGCTCCTTTATCA-
CCTTC-3, and antisense: 5-GACTAGTTCGAGACAGAGCAAG-3; 
GAPDH sense, 5-GCACAGTCAAGGCCGAGAAT-3, and antisense, 
5-GCCTTCTCCATGGTGGTGAA-3; Hspd1 sense, 5-ACTTCAGA-
GAAGTCACCTGGA-3, and antisense, 5-GAACAGTAGAGATGCC-
TCAGTG-3; Itgb1 sense, 5-GGTGCTCCTTTATCACCTTC-3, 
and antisense, 5-GACTAGTTCGAGACAGAGCAAG-3; Klf6 sense, 
5-TGGTTCCTAACCTTCTGAGAG-3, and antisense, 5-CCTT-
GGTATACTCCTCACACAC-3; Mt1 sense, 5-AAGTGCACCTCC-
TGCAA-3, and antisense, 5-GGGTGGAACTGTATAGGAAGAC-3; 
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2008a). The researcher who performed all the analysis was blinded to the 
animal’s genotype.
Enforced treadmill exercise and histological analysis. The dystrophic 
animals mdx;Pax7Bmi1, mdx control littermates and C57BL/6J-BL/10 mice 
(2–4 mo) were used in this experiment. Mice were injected with Tamoxifen. 
Starting from 3 d after the last injection, one mouse was put in each lane of the 
treadmill and forced to run at the speed of 12 m/min for 30 min, twice a week 
for 6 wk. This protocol was not exhausting and generally all the mice were able 
to perform the exercise. Whenever an avoiding behavior was observed, the 
mice were stimulated to run by a gentle touch of the tail or with the pres-
ence of a soft barrier at the end of the treadmill lane (De Luca, 2008b). The 
mice were sacrificed 6 d after the last treadmill session. One forelimb was 
embedded in OCT and frozen in isopentane cooled at the liquid nitrogen tem-
perature. The other forelimb was dissected and the muscles snap-frozen in liq-
uid nitrogen to perform RNA extraction and to check Bmi1 expression levels.
The frozen muscles were serially sectioned at 8 µm and processed for 
H&E staining and/or immunohistochemistry. The percentage of CNF was 
counted in the injured area of three different sections along the length of the 
leg for the same animal. The researcher who performed all the analysis was 
blinded to the animal’s genotype.
Assessment of muscle strength. The dystrophic animals mdx;Pax7Bmi1, 
mdx control littermates and C57BL/6J-BL/10 mice (2–4 mo) performing 
the enforced treadmill exercise were used in this experiment. Before each 
treadmill session, a forelimb grip test was performed (De Luca, 2008c) to as-
sess the course of the disease. The test was performed using a horizontal grip 
strength meter (Linton). In brief, each mouse was lifted by the tail toward 
the metal pull bar. Once the mouse had grasped the bar with the forelimbs, 
the mouse was pulled back in a horizontal plane. The protocol was repeated 
three consecutive times within 30 s. The grip strength was normalized against 
the body weight.
Cell transplantation experiments. Satellite cells isolated from 
mdx;STOPFloxBmi1 were treated as for the MT1 kd experiments. 6 d later, 
cells were harvested and 20,000 cells were transplanted into surgically ex-
posed TA muscles of 3-wk-old mdx mice. After 27 d, the muscle tissues were 
fixed in 4% PFA for 6 h, left on in 30% sucrose, and embedded in OCT.
Serial sections (8 µm thick) were cut, mounted, and analyzed at the mi-
croscope for GFP positivity (two sections/mouse; three fields/section). The 
same settings were applied to take pictures of MT1 kd and MT1 SCr trans-
planted mice. For the analysis of the strong GFP positivity a defined thresh-
old was applied to all pictures and the GFP+ve fibers were counted out of the 
total number of fibers/microscopic field. The percentage of strong GFP+ve 
fibers was calculated out of the total number of GFP+ve fibers/field. The re-
searcher who performed all the analysis was blinded to the different treat-
ments of the transplanted satellite cells.
Microarray analysis. Three independently prepared satellite cell cultures iso-
lated from STOPFloxBmi1 mice, treated with A-Cre infection and induced to 
differentiate for 2 d were analyzed by whole-genome Illumina platform mouse 
v2 as compared with the same cells treated with A-GFP. Integrity of starting 
total RNA was evaluated using capillary electrophoresis (Bioanalyzer 2100; 
Agilent Technologies) and quantified using a NanoDrop 1000 (NanoDrop). 
Aliquots of RNA (250 ng) samples were amplified according to the specifica-
tions of the Illumina TotalPrep RNA Amplification kit (Ambion). The cRNA 
samples obtained were applied to the MouseWG-6 v2.0 Expression BeadChip 
arrays (Illumina) and hybridized according to the manufacturer’s specification. 
Each array on the BeadChip targets >45,200 transcripts using 3-µm beads 
bearing covalently attached 50-base oligonucleotide probes. The BeadChips 
were scanned with the BeadSrray system scanner (Illumina). The hybridization 
images signal intensity was extracted and background subtracted using Bead-
Studio software (version 3.3.7 Illumina). The data discussed in this publication 
have been deposited in NCBI’s Gene Expression Omnibus and are accessible 
through GEO Series accession no. GSE41878.
Modified biotin switch assay to detect SNO-MEF2c. The biotin-
switch assay (BST) is a modified immunoblot analysis used to detect the 
levels of S-nitrosylated proteins. Here, we used a modified version of this 
assay. In brief, cell lysates were prepared from A-Cre– or A-GFP–treated 
mdx;STOPFloxBmi1 satellite cell cultures in HENS Buffer (Pierce 
S-Nitrosylation Western Blot kit; Thermo Fisher Scientific) and the BCA 
Protein Assay was used (Thermo Fisher Scientific) to determine the protein 
concentration. 300 µg of protein from each sample was mixed with 20 mM 
methyl methane thiosulfonate (MMTS) for 30 min at room temperature to 
block free thiol groups. After removing excess MMTS by acetone precipita-
tion (1 h at 20°C), S-nitrosothiols were reduced to thiols with 20 mM 
sodium ascorbate. In the negative control, ultrapure water was used instead 
of sodium ascorbate. Labeling reagent containing tandem mass tag (TMT) 
was added to label the newly formed thiols. After acetone precipitation, 
samples were resuspended into HENS buffer. TMT labeled proteins were 
loaded onto spin columns with pre-added immobilized anti-TMT resin 
(Thermo Fisher Scientific) and eluted. The eluted proteins were concen-
trated using Pierce Concentrator (Thermo Fisher Scientific) and further ana-
lyzed by immunoblotting. Input was used for the control blot.
Pax7CreERT2T2 tamoxifen injection. Tg:Pax7CreERT2 mice were 
crossed with R26R to optimize the injections protocol. 2-mo-old littermate 
Pax7CreERT2;R26R and R26R (as controls) were injected with Tamoxifen 
(Sigma-Aldrich) 20 mg/ml suspended in corn oil (Sigma-Aldrich; 4.5 mg/40 g 
of body weight) twice a day for five consecutive days. 5 d after the last injec-
tion the mice were culled and the efficiency of recombination was assessed. 
Pax7CreERT2 mice were bred with the STOPFloxBmi1 mice to overexpress 
Bmi1 in a cell type–specific fashion and the mdx mice for the experi-
ments in a dystrophic model. In particular, the following compound mu-
tant mice were generated: Pax7CreERT2;STOPFloxBmi1 (Pax7Bmi1) and 
mdx;Pax7CreERT2;STOPFloxBmi1 (mdx;Pax7Bmi1).
Acute muscle injury and histological analysis. Pax7Bmi1 and littermate 
control mice (2–4 mo) were used in this experiment. Mice were injected 
with Tamoxifen (as described above) to induce Bmi1 overexpression in sat-
ellite cells. 10 d after the last injection, muscle freeze injury (FZ) was per-
formed on these mice. 2% isoflurane inhalation was used to anesthetize the 
mice. The left hind limb was shaved and then wet with 70% ethanol to re-
move hair. To induce the damage to the Tibialis Anterior (TA) muscle, an 
incision of 5 mm was done in the skin above the muscle; then, a dry ice pre-
cooled probe was applied on the muscle for 10 s. The incision was closed by 
veterinary glue (VETBOND Tissue Adhesive). The mice were either sacri-
ficed or used in a test for treadmill performance 10 d.a.i. Both the injured 
and contralateral hind limbs were collected. The injured leg was embedded 
in OCT and frozen in liquid nitrogen-precooled isopentane, whereas the 
contralateral muscles were snap-frozen in liquid nitrogen and processed for 
RNA extraction to check Bmi1 expression levels.
The frozen muscles were serially sectioned at 8 µm (with a step of 120 µm) 
and processed for H&E staining and/or immunohistochemistry. The per-
centage of CNF was counted in the injured area of three different sections 
along the length of the leg for each animal. In the same sections, the cross-
sectional areas (CSAs) of the fibers in regenerating and uninjured areas 
(as control) were measured using the MetaMorph software (Life Sciences 
Research Imaging Systems). The researcher who performed all the analy-
sis was blinded to the animal’s genotype.
Treadmill performance test after FZ injury. Tamoxifen-injected 
Pax7Bmi1 and littermate controls mice (2–4 mo) were used in this experiment. 
10 d after the muscle freeze injury mice performed a functional test running on 
a treadmill (LE8710M, Panlab Harvard Apparatus). 3 d before the test, mice 
were trained for each day for 5 min, at the speed of 10 m/min, with an incli-
nation of 5°. The day of the test, the mice started running for 4 min (speed 
10 m/min) and then every 4 min the speed was increased of 2 m/min until 
the mice were tired. Tiredness was defined as the inability of the mouse to 
go back to the treadmill belt despite five mechanical stimulations (De Luca, 
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